Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
Andres J YarurV KanagalaD J SteinF CzulM A QuinteroD AgrawalA PatelK BestC FoxK IdsteinM T AbreuPublished in: Alimentary pharmacology & therapeutics (2017)
There is a significant association between serum infliximab levels and rates of fistula healing. Achieving infliximab levels ≥10.1 mcg/mL in patients with Crohn's disease and perianal fistulas may improve outcomes as part of a treat-to-target strategy.
Keyphrases